Skip to main content

Table 1 Baseline patients’ criteria (n = 781)

From: Performance of Albumin-Bilirubin (ALBI) score in comparison to other non-invasive markers in the staging of liver fibrosis in chronic HCV patients

Variables

Median (IQR)/ Number (%)

Age (years)

55 (48–60)

Gender, Male n (%)

488 (62.48%)

BMI (Kg/m2)

29.34 (26.57–32.7)

Laboratory parameters

 WBCs

5.7 (4.6–7.1)

 Hemoglobin

14.2 (12.9–15.4)

 Platelets

160 (125–218)

 ALT

48 (33–75)

 AST

46 (32.8–69)

 Total bilirubin

0.7 (0.5–0.9)

 Albumin

4.1 (3.7–4.4)

 INR

1.1 (1.01–1.2)

 HCV RNA

654 × 103 (162133–186 × 104)

Fibrosis stages

 F0

108 (13.8%)

 F1

56 (7.17%)

 F2

101 (12.9%)

 F3

95 (12.16%)

 F4

421 (53.9%)

Liver fibrosis parameters

 FIB-4

2.27 (1.40–3.49)

 APRI

0.78 (0.47–1.37)

 ALBI score

-2.77 (-3.05- -2.43)

 LOK index

0.51 (0.32–0.70)

 GUCI

0.88 (0.50–1.55)

 Liver stiffness

13.8 (7.7–23.4)

  1. Numerical data presented as median (IQR)